Skip to main content

Day: November 29, 2021

Immutable Holdings Announces Upsize to Previously Announced Marketed Private Placement to $14 Million Due to Strong Investor Demand

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. VANCOUVER, British Columbia, Nov. 29, 2021 (GLOBE NEWSWIRE) — Immutable Holdings Inc. (NEO:HOLD) (“Immutable Holdings” or the “Company”), a publicly-traded blockchain holding company, is pleased to announce that it has entered into an agreement with Stifel GMP (the “Lead Agent”) pursuant to which the Company and the Lead Agent have agreed to: (i) increase the size of the previously announced marketed offering of units of the Company (“Units”) at an offering price of $2.60 per Unit from up to $10 million to up to $14 million (the “Offering”); and (ii) increase the size of the agents’ option on the Offering (the “Agents’ Option”) to 1,153,846 Units, which...

Continue reading

Dundee Precious Metals Re-Issues Technical Report on the Loma Larga Project

TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) today announced that the Company has refiled a technical report for the Loma Larga development project located in Ecuador. Loma Larga was acquired by DPM as a result of its acquisition of INV Metals Inc., which was completed on July 26, 2021. The technical report, dated November 29, 2021, was originally prepared and filed by INV Metals Inc. with an effective date of April 8, 2020, and the technical information contained in the report is unchanged. The technical report was readdressed to DPM and was filed in accordance with section 4.2(7) of National Instrument 43-101. The technical report is available for review on SEDAR (www.sedar.com) and on the Company’s website (www.dundeeprecious.com). About Dundee Precious Metals Dundee...

Continue reading

Voxtur Announces Record Results for Q3 2021 Ended September 30, 2021

Voxtur achieves 402% year-over-year growth for Q3 2021 Q3 2021 HighlightsRevenue was $24.7 million, representing a 37% increase over Q2 2021 and a 402% increase over Q3 2020 Gross Margin was $9.5 million, representing a 15% increase over Q2 2021 and a 359% increase over Q3 2020 91% of Revenue for Q3 2021 was derived from U.S. Operations — up from 61% in Q3 2020 Voxtur closed the acquisition of Xome Valuations in Q3 2021 The Company ended Q3 2021 with cash and cash equivalents of $37.9 millionTORONTO and TAMPA, Fla., Nov. 29, 2021 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) (“Voxtur” or the “Company”), a technology company creating a more transparent and accessible real estate lending ecosystem, announced today its Unaudited Condensed Interim Consolidated Financial Statements...

Continue reading

AGF Announces Investment Objective and Strategy Changes to AGFiQ U.S. Market Neutral Anti-Beta Fund

BOSTON, Nov. 29, 2021 (GLOBE NEWSWIRE) — AGF Investments LLC announced today the Board of Trustees of AGF Investments Trust has approved changes to the investment objective and principal investment strategies of AGFiQ U.S. Market Neutral Anti-Beta Fund (Ticker: BTAL) (the “Fund”), effective after satisfying regulatory and listing exchange requirements on or about February 14, 2022. The Fund will change from a passive, index tracking strategy to a rules-based, active strategy. The Fund will continue to be fully transparent. There are no anticipated changes to the Fund’s name, ticker symbol, fees and expenses, portfolio managers or its performance benchmark. Currently, the Fund seeks performance results that correspond to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Thematic Market Neutral Low...

Continue reading

Theralase Releases 3Q21 Financial Statements and Newsletter

TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) — Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated compounds and their associated drug formulations with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses has released the Company’s unaudited 3Q2021 condensed interim consolidated Financial Statements (“Financial Statements”), which provides financial information on the previous fiscal quarter and the quarterly Newsletter (“Newsletter”) which provides an interim clinical data analysis on the Phase II Non-Muscle Invasive Bladder Cancer (“NMIBC“) clinical study (“Study II”). The Financial Statements can be found on the Company’s...

Continue reading

Pasithea Therapeutics Corp. Announces Closing of $30.4 Million Private Placement Priced at a Premium to the Market Under Nasdaq Rules

MIAMI BEACH, Fla., Nov. 29, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA; KTTAW) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders, today announced the closing of its previously announced private placement of common stock and warrants priced at a premium to the market under Nasdaq rules. The Company sold an aggregate of 8.68 million shares of common stock and warrants to purchase 8.68 million shares of common stock at a purchase price of $3.50 per share and accompanying warrant for gross proceeds to the Company of $30.4 million, before deducting the placement agent’s fees and other estimated offering expenses. The warrants will be immediately exercisable from the date of issuance and have...

Continue reading

Array Technologies, Inc. Announces Proposed Private Offering of $325 Million of Convertible Senior Notes

ALBUQUERQUE, N.M., Nov. 29, 2021 (GLOBE NEWSWIRE) — Array Technologies, Inc. (NASDAQ: ARRY) (the “Company” or “Array”) today announced that, subject to market conditions, it intends to offer $325 million in aggregate principal amount of convertible senior notes due 2028 (the “Notes”) in a private placement (the “Offering”) to eligible purchasers under Rule 144A of the Securities Act of 1933, as amended (the “Securities Act”). Array also intends to grant the initial purchasers of the Notes an option to purchase, within a 13-day period from, and including the date on which the Notes are first issued, up to an additional $48.75 million aggregate principal amount of Notes. Array intends to use the net proceeds from the Offering, together with cash on hand and/or borrowings under its revolving credit facility and the issuance of up...

Continue reading

Navigator Holdings Ltd. Preliminary Third Quarter 2021 Results (Unaudited)

HighlightsNavigator Holdings Ltd. (the “Company”, “we”, “our” and “us”) (NYSE: NVGS) reported operating revenue of $102.7 million for the three months ended September 30, 2021, compared to $81.4 million for the three months ended September 30, 2020.Net income was $6.7 million (earnings per share of $0.10) for the three months ended September 30, 2021, compared to a net income of $1.3 million (earnings per share of $0.02) for the three months ended September 30, 2020. Adjusted EBITDA(1) was $40.3 million for the three months ended September 30, 2021, compared to $29.6 million for the three months ended September 30, 2020. Fleet utilization was 84.0% for the three months ended September 30, 2021, an increase from the 78.8% achieved for the three months ended September 30, 2020. The ethylene export marine terminal at Morgan’s Point,...

Continue reading

Yooma Wellness Reports Results for Third Quarter of 2021

Significant Growth and Operational Progress Achieved in the Third Quarter TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) — Yooma Wellness Inc. (“Yooma” or the “Company“) (CSE: YOOM, AQSE:YOOM), a Toronto-based vertically-integrated global wellness platform that develops and markets a portfolio of wellness brands, today released its interim financial statements (the “Financial Statements“) for the three-month period ended September 30, 2021 (the “Reporting Period“).   A summary of Yooma’s operational and financial highlights during the Reporting Period are set out below and more detailed information is contained in the Financial Statements and related Management Discussion and Analysis which are available on Yooma’s SEDAR page at www.sedar.com. Lorne Abony, Chairman at Yooma,...

Continue reading

Media Central Releases Financial Results For Three and Nine Months Ending Sept. 30, 2021

The Company Also Announced It Has Hired Investment Bank Foundation Markets To Restructure Its Debt And Raise Fresh Capital To Support Its 2022 Growth Plan TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) — Media Central Corporation, Inc. (CSE: FLYY; FSE: 3AT) (“Media Central” or the “Company” or “we” or “us”) today released its internal financial statements for the three and nine months ending November 30, 2021. The Company also announced it has retained Toronto-based Foundation Markets to restructure its debt and raise new investment capital to support its 2022 growth plan. NOW Magazine and the Georgia Straight delivered significant third quarter 2021 improvements compared to the third quarter 2020 in two key operating performance measures, as further described below (all amounts presented in ‘000 of Canadian dollars). Both NOW and the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.